Society Letters

CAMT Letter to the NIH and FDA on COVID-19 Vaccine and Therapeutics Development

March 18, 2020

To: CMS Administrator Seema Verma 

"We strongly urge CMS to consider the items that we have proposed and act immediately to address these barriers to care and to implement these changes nationally for all Medicare beneficiaries with diabetes.
It is vital that all Medicare beneficiaries with diabetes, especially those who are newly diagnosed with diabetes, have access to DSMT services during this critical time. DSMT services, provided by diabetes care and education specialists through our accredited programs, offer essential support for people with diabetes."

arrow Read the Full Letter

Last Updated:
Take Action

Make Your Voice Heard

We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.